Vor Biopharma VOR
NASDAQ VOR
$20.09 +0.53 (+2.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Vor Biopharma (VOR) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Vor Biopharma's Net Equity Issued and Repurchased came in at $48.4 million for Q3 2026, up 138.9% from $20.26 million a year earlier.

Analysis

Vor Biopharma (VOR) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Vor Biopharma reported Net Equity Issued and Repurchased of $323.25 million, up 28.9% year-over-year; for FY2025, it came in at $395.11 million, up 607.8% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 36.8% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $55.83 million in FY2024, $4.58 million in FY2023 (+2.9%), $4.45 million in FY2022 (-98.1%) and $234.57 million in FY2021 (+184.2%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is -$246,000 (Q4 2021) to $199.85 million (Q4 2025).
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2025 (growth of 259.9%), and the weakest in Q2 2026 (a decline of 100.0%).
  • Business Quant data shows VOR's Net Equity Issued and Repurchased at $3,000 (Q2 2026), $75 million (Q1 2026) and $199.85 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vor Biopharma 1.20 Bn -692.85 Mn - 48.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 48.84 Mn
Jun 30, 2026 3,000.00
Mar 31, 2026 75.00 Mn
Dec 31, 2025 199.98 Mn
Sep 30, 2025 22.21 Mn
Jun 30, 2025 175.00 Mn
Dec 31, 2024 55.64 Mn
Sep 30, 2024 111,000.00
Jun 30, 2024 -92,000.00
Mar 31, 2024 278,000.00
Dec 31, 2023 47,000.00
Sep 30, 2023 396,000.00
Jun 30, 2023 565,000.00
Mar 31, 2023 3.64 Mn
Dec 31, 2022 737,000.00
Sep 30, 2022 4.08 Mn
Jun 30, 2022 304,000.00
Mar 31, 2022 200,000.00
Dec 31, 2021 -246,000.00
Sep 30, 2021 201,000.00
API Access

Vor Biopharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VOR&period=max&api_key=YOUR_API_KEY